In addition, the authors indicated that S3M could detect aggressive cancer even in men with PSA levels of 1.5–3 ng/mL, and the number of tumours with a Gleason score ≤6 was reduced by 17%, reducing overdiagnosis. This evidence concerns the gene KLK3 and cancer.